Cenobamate: payments to doctors
Payments that named Cenobamate as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.3M
- Providers
- 593
- Transactions
- 1,962
- Average per transaction
- $665
The per-transaction average — $665 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 593 providers the average total is $2,202, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| SK Life Science, Inc. | $1,305,694 | 100.0% |